Pale Fire Capital SE »

Tarsus Pharmaceuticals shares owned by Pale Fire Capital SE

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Pale Fire Capital SE from 13F filings

Historical chart of Pale Fire Capital SE investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Pale Fire Capital SE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Pale Fire Capital SE

Quarter filed Position value Share count Share price at filing
2025-09-30 $421k 7.1k 59.43

More positions owned by Pale Fire Capital SE

B2gold Corp (BTG)
Groupon Com New (GRPN)
Dole Ord Shs (DOLE)
Iamgold Corp (IAG)
New Gold Inc Cda (NGD)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Centerra Gold (CGAU)
Angi Cl A New (ANGI)
I-80 Gold Corp (IAUX)
Mineralys Therapeutics (MLYS)
J Global (ZD)
Galiano Gold (GAU)
Tsakos Energy Navigation SHS (TEN)
Atai Life Sciences Nv SHS (ATAI)
Liquidia Corporation Com New (LQDA)

View all positions for Pale Fire Capital SE

Top funds holding Tarsus Pharmaceuticals

BlackRock
Rtw Investments
Deep Track Capital
Paradigm Biocapital Advisors
Jennison Associates
Tang Capital Management
Vanguard Group
Morgan Stanley
Henderson Group
Assenagon Asset Management
Frazier Life Sciences Management
Driehaus Capital Management
Lord, Abbett & Co
Geode Capital Management
Invesco

View all funds holding Tarsus Pharmaceuticals